✦ LIBER ✦

Effect of adiponectin and sex steroid hormones on bone mineral density and bone formation markers in postmenopausal women with subclinical hyperthyroidism

✍ Scribed by Ki Hoon Ahn; Seung Hyeun Lee; Hyun Tae Park; Tak Kim; Jun Young Hur; Young Tae Kim; Sun Haeng Kim

Book ID: 109007200
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 181 KB
Volume: 36
Category: Article
ISSN: 1341-8076
DOI: 10.1111/j.1447-0756.2009.01132.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of alendronate and risedronate o

Effects of alendronate and risedronate on bone mineral density and bone turnover markers in late postmenopausal women with osteoporosis

✍ Aysegul Atmaca; Olcay Gedik 📂 Article 📅 2006 🏛 Springer Healthcare Communications 🌐 English ⚖ 279 KB

The influence of ghrelin, adiponectin, a

The influence of ghrelin, adiponectin, and leptin on bone mineral density in healthy postmenopausal women

✍ Jaak Jürimäe; Toivo Jürimäe; Aire Leppik; Tatjana Kums 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 219 KB

The study of bone mineral density and bo

The study of bone mineral density and bone turnover markers in postmenopausal women with active rheumatoid arthritis

✍ Shigeki Momohara; Hiroshi Okamoto; Toru Yago; Takefumi Furuya; Yuki Nanke; Shige 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 384 KB

Dose–response study of denosumab on bone

Dose–response study of denosumab on bone mineral density and bone turnover markers in Japanese postmenopausal women with osteoporosis

✍ T. Nakamura; T. Matsumoto; T. Sugimoto; M. Shiraki 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 500 KB

Effects of bazedoxifene on bone mineral

Effects of bazedoxifene on bone mineral density, bone turnover, and safety in postmenopausal japanese women with osteoporosis

✍ Akira Itabashi; Kousei Yoh; Arkadi A Chines; Takami Miki; Masahiko Takada; Hiros 📂 Article 📅 2011 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 244 KB 👁 2 views

## Abstract This randomized, double‐blind, placebo‐controlled, dose‐response late phase 2 study evaluated the efficacy and safety of bazedoxifene in postmenopausal Japanese women 85 years of age or younger with osteoporosis. Eligible subjects received daily treatment with oral doses of bazedoxifene

Commencing, Continuing and Stopping Bris

Commencing, Continuing and Stopping Brisk Walking: Effects on Bone Mineral Density, Quantitative Ultrasound of Bone and Markers of Bone Metabolism in Postmenopausal Women

✍ K. Brooke-Wavell; P. R. M. Jones; A. E. Hardman; I. Tsuritani; Y. Yamada 📂 Article 📅 2001 🏛 Springer-Verlag 🌐 English ⚖ 119 KB